f A Comprehensive Report on Long COVID, Emerging Challenges, and Research Priorities in the Pandemic

References

1. ThaweethaiT. JolleyS.E. KarlsonE.W. Development of a definition of postacute sequelae of SARS-CoV-2 infection.JAMA2023329221934194610.1001/jama.2023.8823 37278994
   [Google Scholar]
2. DavisH.E. McCorkellL. VogelJ.M. TopolE.J. Long COVID: Major findings, mechanisms and recommendations.Nat. Rev. Microbiol.202321313314610.1038/s41579‑022‑00846‑2 36639608
   [Google Scholar]
3. KomaroffA.L. LipkinW.I. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature.Front. Med.202310118716310.3389/fmed.2023.1187163 37342500
   [Google Scholar]
4. DhamaK. KhanS. TiwariR. Coronavirus disease 2019–COVID-19.Clin. Microbiol. Rev.2020334e00028e2010.1128/CMR.00028‑20 32580969
   [Google Scholar]
5. MizrahiB. SudryT. ManovF.N. Long covid outcomes at one year after mild SARS-CoV-2 infection: Nationwide cohort study.BMJ2023380e07252910.1136/bmj‑2022‑072529
   [Google Scholar]
6. CarabelliA.M. PeacockT.P. ThorneL.G. SARS-CoV-2 variant biology: Immune escape, transmission and fitness.Nat. Rev. Microbiol.202321316217710.1038/s41579‑022‑00841‑7 36653446
   [Google Scholar]
7. DuM. MaY. DengJ. LiuM. LiuJ. Comparison of long COVID-19 caused by different SARS-CoV-2 strains: A systematic review and meta-analysis.Int. J. Environ. Res. Public Health202219231601010.3390/ijerph192316010
   [Google Scholar]
8. NittasV. GaoM. WestE.A. Long COVID through a public health lens: An umbrella review.Public Health Rev.202243160450110.3389/phrs.2022.1604501 35359614
   [Google Scholar]
9. BuonsensoD. PiazzaM. BonerA.L. BellantiJ.A. Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome.Allergy Asthma Proc.202243318719310.2500/aap.2022.43.220018
   [Google Scholar]
10. HuY. LiuY. ZhengH. LiuL. Risk factors for long COVID in older adults.Biomedicines20231111300210.3390/biomedicines11113002 38002002
    [Google Scholar]
11. EveringT.H. MoserC.B. JilgN. Long COVID after bamlanivimab treatment.J. Infect. Dis.2023228S2S126S13510.1093/infdis/jiad286 37650236
    [Google Scholar]
12. ShabnamS. RaziehC. MillerD.H. Socioeconomic inequalities of Long COVID: A retrospective population-based cohort study in the United Kingdom.J. R. Soc. Med.2023116826327310.1177/01410768231168377 37164035
    [Google Scholar]
13. SukochevaO.A. MaksoudR. BeerakaN.M. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.J. Adv. Res.20224017919610.1016/j.jare.2021.11.013 36100326
    [Google Scholar]
14. KocH.C. XiaoJ. LiuW. LiY. ChenG. Long COVID and its management.Int. J. Biol. Sci.202218124768478010.7150/ijbs.75056 35874958
    [Google Scholar]
15. GaoP. LiuJ. LiuM. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: A systematic review and meta-analysis.Int. J. Environ. Res. Public Health202219191242210.3390/ijerph191912422 36231717
    [Google Scholar]
16. LiG. HilgenfeldR. WhitleyR. De ClercqE. Therapeutic strategies for COVID-19: Progress and lessons learned.Nat. Rev. Drug Discov.202322644947510.1038/s41573‑023‑00672‑y 37076602
    [Google Scholar]
17. HansenC.B. SandholdtH. MøllerM.E.E. Prediction of respiratory failure and mortality in COVID-19 patients using long pentraxin PTX3.J. Innate Immun.202214549350110.1159/000521612 35066500
    [Google Scholar]
18. MenezS. CocaS.G. MoledinaD.G. Evaluation of plasma biomarkers to predict major adverse kidney events in hospitalized patients with COVID-19.Am. J. Kidney Dis.2023823322332.e110.1053/j.ajkd.2023.03.010 37263570
    [Google Scholar]
19. TaylorK. PearsonM. DasS. SardellJ. ChocianK. GardnerS. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.J. Transl. Med.202321177510.1186/s12967‑023‑04588‑4 37915075
    [Google Scholar]
20. AlenazyM.F. AljoharH.I. AlruwailiA.R. Gut microbiota dynamics in relation to Long-COVID-19 syndrome: Role of probiotics to combat psychiatric complications.Metabolites2022121091210.3390/metabo12100912 36295814
    [Google Scholar]